Eckert GJ

ORCID: 0000-0001-7798-7155 · 1 paper in corpus

2025

A randomized, double blind, placebo-controlled pilot study to assess the efficacy of erenumab in individuals with temporomandibular disorder.

Journal of oral & facial pain and headache ·doi:10.22514/jofph.2025.027

BackgroundErenumab has proven efficacious in treating migraine headache. Temporomandibular disorder (TMD) is a painful disorder which has high co-occurrence rates with migraine. We hypothesized that erenumab-aooe may also be beneficial in r…